Cleared Special

K063113 - EP-WORKMATE

K063113 is an FDA 510(k) clearance for EP-WORKMATE, manufactured by Ep Medsystems. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 16-day FDA review.

K063113 · Ep Medsystems · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2006
Decision
16d
Days
Class 2
Risk

K063113 is an FDA 510(k) clearance for the EP-WORKMATE. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Ep Medsystems (West Berlin, US). The FDA issued a Cleared decision on October 27, 2006 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K063113

510(k) Number K063113 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 11, 2006
Decision Date October 27, 2006
Days to Decision 16 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
109d faster than avg
Panel avg: 125d · This submission: 16d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 428
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K063113.
CARDIODAY, VERSION 2.0
K070280 · Getemed Medizin- Und Informationstechnik AG · Feb 2007
MAPMATE
K063277 · Ep Medsystems, Inc. · Nov 2006
HORIZON CARDIOLOGY ECG-MCKESSON'S ECG MANAGEMENT SYSTEM, MODEL 1.0
K061905 · Medcon , Ltd. · Nov 2006
MAC-LAB/CARDIOLAB /COMBOLAB/SPECIALSLAB SYSTEM
K061741 · Ge Healthcare · Sep 2006
MODIFICATION TO ENSITE SYSTEM, MODEL EE3000
K060954 · St. Jude Medical, Inc.-Endocardial Solutions · Apr 2006
NOGA XP CARDIAC NAVIGATION SYSTEM WITH QWIKMAP SOFTWARE
K053194 · Biosense Webster, Inc. · Mar 2006
K063113 · EP-WORKMATE
Download PDF FDA Summary Ep Medsystems